Clinical Trial

Evaluation of GM101 Injection in Patients With Parkinson's Disease

Name: Evaluation of GM101 Injection in Patients With Parkinson's Disease — clinical trial record (NCT07100171)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The objective of this study is to assess the safety of GM101 in participants with Parkinson's disease (PD)

Trial Details

NCT Number	NCT07100171
Lead Sponsor	Genemagic Biosciences Co., Ltd
Conditions	Parkinson's Disease
Enrollment	10 participants
Start Date	2025-05-29
Primary Completion	2027-02-17 (estimated)
Study Completion	2030-02-17 (estimated)
Updated on ClinicalTrials.gov	2025-08-03